Enalapril
-
Subject Areas on Research
- A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women.
- ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation.
- Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation.
- Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists.
- Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
- Angiotensin-Neprilysin Inhibition in Black Americans: Data From the PIONEER-HF Trial.
- Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial.
- Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial.
- Comparison of echocardiographic measurements to invasive measurements of diastolic function in infants with single ventricle physiology: a report from the Pediatric Heart Network Infant Single Ventricle Trial.
- Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
- Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial.
- Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial.
- Enalapril and hydroxyurea therapy for children with sickle nephropathy.
- Enalapril in infants with single ventricle: results of a multicenter randomized trial.
- Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure.
- Growth Asymmetry, Head Circumference, and Neurodevelopmental Outcomes in Infants with Single Ventricles.
- Heart failure with preserved ejection fraction in the elderly: scope of the problem.
- Impact of enalapril therapy on in vitro coronary artery responsiveness in pacing-induced heart failure.
- Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial.
- Left ventricular myocardial blood flow, metabolism, and effects of treatment with enalapril: further insights into the mechanisms of canine experimental pacing-induced heart failure.
- Lessons learned from a pediatric clinical trial: the Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study.
- Prescribing BiDil: is it black and white?
- Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.
- Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril.
- Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.
- Quality of life among hypertensive patients with a diuretic background who are taking atenolol and enalapril.
- Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle.
- Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial.
- Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
- Role of angiotensin II and vasopressin in cisplatin-induced emesis.
- Safety of Enalapril in Infants Admitted to the Neonatal Intensive Care Unit.
- Significance of the vascular renin-angiotensin pathway.
- Translating clinical trials into clinical practice: a survey assessing the potential impact of the Pediatric Heart Network Infant Single Ventricle Trial.
- Vasodilators in aortic regurgitation.
-
Keywords of People
- Barker, Piers Christopher Andrew, Professor of Pediatrics, Pediatrics, Cardiology